𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new strategy for clinical decision making: Censors and neuroendocrinological diseases

✍ Scribed by Hormoz Mansour; Mark E. Molitch

Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
648 KB
Volume
16
Category
Article
ISSN
0010-4825

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A new strategy for clinical decision mak
A new strategy for clinical decision makingβ€”II. The circumscription of non-monotonicity and differential diagnosis for thyroid diseases
✍ Hormoz Mansour πŸ“‚ Article πŸ“… 1989 πŸ› Elsevier Science 🌐 English βš– 515 KB

The physician or scientist must contend with multiple interactions in medicine. Differential diagnosis, or the determination of which of two or more diseases a patient is suffering from, arises from the complexity of these interactions. Some of these interactions can mask or inhibit the true diagnos

Disease risk analysis: a tool for primat
Disease risk analysis: a tool for primate conservation planning and decision making
✍ D.A. Travis; L. Hungerford; G.A. Engel; L. Jones-Engel πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 157 KB

## Abstract Concern about emerging and re‐emerging diseases plays an increasing role in conservation and management of both captive and free‐ranging nonhuman primates (NHPs). Managers and policy makers must formulate conservation plans in an arena plagued by uncertainty, complexity, emotion, and po

Everolimus drug interactions: applicatio
Everolimus drug interactions: application of a classification system for clinical decision making
✍ John M. Kovarik; Doris Beyer; Robert L. Schmouder πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract __Introduction__. More than half of all drugs used in medical practice are metabolized by cytochrome CYP3A. Coadministration of drugs that share this elimination pathway may lead to pharmacokinetic drug interactions. Efforts are underway by clinical, drug development and regulatory scie